XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Beginning balance (in shares) at Jan. 02, 2022     197,000            
Beginning balance at Jan. 02, 2022 $ 10,740 $ (32) $ 2 $ 8,938 $ (93) $ 17 $ 5,485 $ 61 $ (3,702)
Beginning balance (in shares) at Jan. 02, 2022                 (40,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (4,404)           (4,404)    
Unrealized loss on cash flow hedges, net of deferred tax (14)         (14)      
Issuance of common stock, net of repurchases (in shares)     1,000            
Issuance of common stock, net of repurchases 10     63         $ (53)
Share-based compensation 299     299          
Ending balance (in shares) at Jan. 01, 2023     198,000            
Ending balance at Jan. 01, 2023 $ 6,599   $ 2 9,207   3 1,142   $ (3,755)
Ending balance (in shares) at Jan. 01, 2023                 (40,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] ASU 2020-06                
Net loss $ (1,161)           (1,161)    
Unrealized loss on cash flow hedges, net of deferred tax (4)         (4)      
Issuance of common stock, net of repurchases (in shares)     1,000            
Issuance of common stock, net of repurchases 27     64         $ (37)
Share-based compensation 275     275          
Reclassification of liability-classified awards $ 9     9          
Ending balance (in shares) at Dec. 31, 2023 159,000   199,000            
Ending balance at Dec. 31, 2023 $ 5,745   $ 2 9,555   (1) (19)   $ (3,792)
Ending balance (in shares) at Dec. 31, 2023 (40,000)               (40,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss $ (1,223)           (1,223)    
Unrealized loss on cash flow hedges, net of deferred tax 23         23      
Issuance of common stock, net of repurchases (in shares)     1,000           (1,000)
Issuance of common stock, net of repurchases (91)     51         $ (142)
Share-based compensation 318     318          
Spin-Off of GRAIL (see Note 2) $ (2,399)     (2,399)          
Ending balance (in shares) at Dec. 29, 2024 159,000   200,000            
Ending balance at Dec. 29, 2024 $ 2,373   $ 2 $ 7,525   $ 22 $ (1,242)   $ (3,934)
Ending balance (in shares) at Dec. 29, 2024 (41,000)               (41,000)